TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
NPCE

Neuropace Inc

Healthcare · Medical Devices · —

14.30$ +0.9% vs. previous close Closing price · As of: Sep 18, 2026

Ownership

Ownership Structure

Who owns Neuropace Inc (NPCE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 74.2% of the shares are freely tradable; institutional investors hold 96.3%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 96.3%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 4.0%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 74.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 3.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 34Mio.

Largest Shareholders

Institutions

Institutions NPCE
Name Stake (%) Shares Change (%) Date
Polar Capital Holdings PLC 9.61 3,298,104 +14.6 03/31/2026
Soleus Capital Management, L.P. 8.48 2,911,122 -0.7 06/30/2026
First Light Asset Management, LLC 8.34 2,861,167 +16.3 06/30/2026
Morgan Stanley - Brokerage Accounts 7.48 2,566,839 +0.7 03/31/2026
BlackRock Inc 6.84 2,346,333 -1.6 03/31/2026
Orbimed Advisors LLC 6.11 2,096,527 -12.9 03/31/2026
Driehaus Capital Management LLC 4.23 1,451,611 -3.9 03/31/2026
Vanguard Capital Management, LLC 3.27 1,123,711 +0.0 03/31/2026
Deutsche Bank AG 2.72 932,090 +0.3 03/31/2026

Funds

Funds NPCE
Name Stake (%) Shares Change (%) Date
Polar Capital Healthcare Opports Inc 8.41 2,888,289 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings NPCE
Person Role Shares Value As of Type
Becker Joel CHIEF EXECUTIVE OFFICER 138,000 1,973,400 $ Sep 3, 2026 direct
Morrell Martha CHIEF MEDICAL OFFICER 51,692 739,196 $ Aug 27, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 3, 2026 Becker Joel CHIEF EXECUTIVE OFFICER Other 1,310 14.75 19,323
Aug 27, 2026 Morrell Martha CHIEF MEDICAL OFFICER Other 358 14.13 5,059
Aug 27, 2026 Becker Joel CHIEF EXECUTIVE OFFICER Other 1,126 14.13 15,910

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?